• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New
50 Pharmacotherapy Studies Every Palliative Practitioner  Should Know

50 Pharmacotherapy Studies Every Palliative Practitioner Should Know

9780197770337
273.71 zł
246.34 zł Save 27.37 zł Tax included
Lowest price within 30 days before promotion: 246.34 zł
Quantity
Teaser
2025-03-31

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
50 Phamarcotherapy Studies Every Palliative Practitioner Should Know is a compilation of key pharmacotherapy studies that form the foundation of evidence-based practice. The studies cover topics including:: agitation and delirium, fatigue, nausea and vomiting, pain, anorexia and cachexia, ALS, seizure, dyspnea, anxiety, pruritis, symptom clusters, COPD, cancer, and more. For each study, a concise summary is presented with an emphasis on the results and limitations of thestudy, and its implications for practice. Brief information on other relevant studies is provided, and an illustrative clinical case offers readers the opportunity to conceptualize findings. As with all books in the 50 Studies series, each study was selected using an objective selection criterion that includedcitations per year, high levels of evidence, clinical studies and trials, and a 3-stage Delphi review by international experts in the field. This book is a must-read for palliative practitioners, pharmacists, advance practice nurses, and physician assistants, and anyone who wants to learn more about the data behind clinical practice.
Product Details
OUP USA
102169
9780197770337
9780197770337

Data sheet

Publication date
2025
Issue number
1
Cover
paperback
Pages count
352
Dimensions (mm)
156 x 235
  • Contributors; 1 Low- Dose Neuroleptics for Treating Delirium; 2 Dexamethasone in Addition to Metoclopramide for Chronic Nausea in Patients With Advanced Cancer; 3 Ibandronate Compared to Radiotherapy for Metastatic Bone Pain in Patients With Solid Tumors; 4 Duloxetine for Cancer- Related Neuropathic Pain; 5 Methadone as a Coanalgesic; 6 Methadone Versus Fentanyl for Nociceptive Cancer Pain; 7 Improving Metastatic Bone Pain With Opioid Adjuvants: Low- Dose Antidepressants and Low- Dose Pregabalin; 8 Intranasal Midazolam Versus Rectal Diazepam for the Home Treatment of Acute Seizures; 9 Isopropyl Alcohol Nasal Inhalation for Nausea in the Emergency Department: A Randomized Controlled Trial; 10 Methylphenidate for Cancer- Related Fatigue; 11 Duloxetine for the Treatment of Chemotherapy- Induced Peripheral Neuropathy; 12 Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial; 13 The Use of Very Low- Dose Methadone for Palliative Pain Control; 14 Opioid Therapy for Dyspnea Associated With Chronic Obstructive Lung Disease: Benefits and Harms; 15 Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life; 16 Palmitoylethanolamide (PEA) as Adjunctive Therapy May Offer Benefit to Patients With Major Depressive Disorder (MDD); 17 Haloperidol as an Adjunct Therapy for Pain and Nausea in Acute Gastroparesis; 18 Neuroleptic Strategies for Terminal Agitation in Patients With Cancer and Delirium at an Acute Palliative Care Unit: A Single- Center, Double- Blind, Parallel- Group, Randomized Trial; 19 Methadone Versus Morphine as a First- Line Strong Opioid for Cancer Pain; 20 Methylnaltrexone for Opioid- Induced Constipation; 21 Lorazepam and Haloperidol Versus Haloperidol Monotherapy for the Treatment of Agitated Delirium; 22 Treatment of Cancer- Related Fatigue With Dexamethasone; 23 Octreotide in Malignant Bowel Obstruction; 24 Efficacy of Levetiracetam, Fosphenytoin, and Valproate for Established Status Epilepticus by Age Group (ESETT): A Double- Blind, Responsive- Adaptive, Randomized Controlled Trial; 25 Donepezil and Memantine for Moderate- to- Severe Alzheimer Disease: When Is It Appropriate to Discontinue Therapy?; 26 Use of Mirtazapine for Cancer- Associated Anorexia and Cachexia; 27 Epidemiology of Amyotrophic Lateral Sclerosis and Effect of Riluzole on Disease Course; 28 Topical Lorazepam, Diphenhydramine, and Haloperidol for Nausea in Cancer Patients; 29 Gabapentin for Uremic Itching; 30 Treatment of Malodorous Tumors With Topical Metronidazole; 31 The Effect of Cannabis on Appetite and Quality of Life in Patients With Cancer- Related Anorexia- Cachexia Syndrome; 32 Olanzapine for the Treatment of Advanced Cancer- Related Chronic ausea and/ or Vomiting; 33 Safety and Benefit of Discontinuing Statin Therapy in Advanced Life-Limiting Illness; 34 Corticosteroids for Cancer- Related Pain, Fatigue, and Anorexia; 35 Role of Paracetamol (Acetaminophen) for Cancer Pain Requiring High-Dose Opioids; 36 Treatment of Painful Wounds With Topical Morphine; 37 Dexamethasone in the Prophylaxis of Radiation- Induced Pain Flare After alliative Radiotherapy for Bone Metastases; 38 Psilocybin for Depression and Anxiety in Cancer Patients; 39 The Use of Opioids for Breakthrough Pain in Acute Palliative Care Unit by sing Doses Proportional to Opioid Basal Regimen; 40 Perioperative Pregabalin for Prevention of Postmastectomy Pain yndrome; 41 Morphine for Chronic Breathlessness; 42 Hyoscine Butylbromide for the Management of Death Rattle; 43 Randomized Controlled Trial of Oral Docusate in Patients on Hospice; 44 Equianalgesic Conversion From Intravenous Hydromorphone to Oral Opiods; 45 Guideline- Driven Versus Single- Agent Antiemetic Therapy in Patients With dvanced Cancer; 46 Safety of Morphine Delivered via Patient- Controlled Analgesia Devices in the Pediatric Population; 47 Efficacy and Safety of Valproic Acid Versus Haloperidol in Patients With; Acute Agitation: Results of a Randomized, Double- Blind, Parallel- Group Trial; Somayeh Yunesian, Alireza Azadbakht, and Ladan Mirmohseni; 48 Ketamine: A Toxic Adjunct in Pain Management for Cancer?; 49 American (Wisconsin) Ginseng for Cancer- Related Fatigue; 50 Management of Intractable Hiccups; Index;
Comments (0)